Journal
CNS DRUGS
Volume 26, Issue 9, Pages 787-790Publisher
ADIS INT LTD
DOI: 10.2165/11209440-000000000-00000
Keywords
-
Categories
Ask authors/readers for more resources
Transdermal granisetron (Sancuso (R)) is effective in the prevention of nausea and vomiting in patients with cancer who are receiving moderately or highly emetogenic chemotherapy for 3-5 days. Transdermal granisetron is noninferior to oral granisetron in this indication, and is generally well tolerated in this indication. Thus, transdermal granisetron provides a convenient option for the prevention of chemotherapy-induced nausea and vomiting, with the potential to improve patient compliance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available